LB
34
8
WDC
41
-2
JPM
63
-4
TXT
48
2
VFC
47
-5
NWS
62
-2
RSG
68
3
NAVI
41
-3
DTE
50
3
COF
55
-3
UNH
61
6
C
58
-2
ADP
64
2
EFX
32
2
MA
55
-7
LH
42
2
PPL
54
2
CINF
47
2
AA
51
3
AIV
68
-4
LB
34
8
WDC
41
-2
JPM
63
-4
TXT
48
2
VFC
47
-5
NWS
62
-2
RSG
68
3
NAVI
41
-3
DTE
50
3
COF
55
-3
UNH
61
6
C
58
-2
ADP
64
2
EFX
32
2
MA
55
-7
LH
42
2
PPL
54
2
CINF
47
2
AA
51
3
AIV
68
-4
Financhill
Back

Eagle Pharmaceuticals Vs. iBio Industry Stock Comparison

Sell
14

EGRX
Eagle Pharmaceuticals

Last Price:
0.90
Seasonality Move:
-5.96%
Sell
22

IBIO
iBio

Last Price:
2.45
Seasonality Move:
-11.6%
Sell
14
Eagle Pharmaceuticals (EGRX) is a Sell

Is Eagle Pharmaceuticals a Buy, Sell or Hold?

  • The current Eagle Pharmaceuticals [EGRX] share price is $0.65. The Score for EGRX is 14, which is 72% below its historic median score of 50, and infers higher risk than normal.
  • EGRX is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
22
iBio (IBIO) is a Sell

Is iBio a Buy, Sell or Hold?

  • The current iBio [IBIO] share price is $2.19. The Score for IBIO is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.
  • IBIO is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

EGRX Stock Price Chart

What is Eagle Pharmaceuticals's stock price today?

  • The Eagle Pharmaceuticals share price today is $0.65
    The current trend is relatively stagnant and EGRX is experiencing selling pressure, which indicates risk of future bearish movement.

IBIO Stock Price Chart

What is iBio's stock price today?

  • The iBio share price today is $2.19
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and IBIO is experiencing selling pressure, which indicates risk of future bearish movement.

EGRX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.22 Sell
Relative Strength Index (14 RSI): 40.32 Sell
Chaikin Money Flow: -2942 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.54 - 0.84) Sell
Bollinger Bands (100): (1.36 - 5.36) Sell

IBIO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.09 Sell
Relative Strength Index (14 RSI): 37.39 Sell
Chaikin Money Flow: -44380 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (2.36 - 2.86) Sell
Bollinger Bands (100): (1.84 - 2.54) Sell

EGRX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.76 Sell
20-day SMA: 0.68 Sell
50-day SMA: 1.74 Sell
200-day SMA: 4.12 Sell
8-day EMA: 0.73 Sell
20-day EMA: 0.83 Sell
50-day EMA: 1.63 Sell
200-day EMA: 4.82 Sell

IBIO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 2.31 Sell
20-day SMA: 2.54 Sell
50-day SMA: 2.4 Sell
200-day SMA: 2.02 Buy
8-day EMA: 2.3 Sell
20-day EMA: 2.44 Sell
50-day EMA: 2.4 Sell
200-day EMA: 3.91 Sell

Eagle Pharmaceuticals Earnings Growth & EGRX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.94 per share, and a decrease next year of $0.00 per share.

iBio Earnings Growth & IBIO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $103.99 per share, and an increase next year of $5.67 per share.

Eagle Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

iBio Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):